
IceCure’s ProSense® Delivers 100% Success Rate in Breakthrough Cryoablation Study, Paving the Way for Non-Surgical Breast Cancer Treatment
IceCure Medical Ltd has announced a landmark achievement with its ProSense® cryoablation system, as detailed in a recent study published in the British Journal of Radiology. The study, conducted at Hospital Lucus Augusti in Lugo, Spain, demonstrates a 100% complete ablation rate for luminal A and B breast cancer tumors ≤ 25mm after a median…